NEPWA
ELOX

New England Private Wealth Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

New England Private Wealth Advisors’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,375
Closed -$249K – 171
2019
Q3 		$249K Buy
1,375
+125
+10% +$35.6K 0.06% 134
2019
Q2 		$499K Sell
1,250
-2,014
-62% -$848K 0.12% 92
2019
Q1 		$1.52M Hold
3,264
– – 0.4% 44
2018
Q4 		$1.57M Buy
+3,264
New +$1.8M 0.46% 37

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New England Private Wealth Advisors's ELOX Position: Q4 2019 in Review

New England Private Wealth Advisors sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2019, closing a stake of 1,375 shares — an estimated $249K sold.

New England Private Wealth Advisors first reported a position in ELOX in Q4 2018 and held it in 4 quarters. The position peaked at $1.57M in Q4 2018. 46 funds tracked by Wall St. Rank hold ELOX as of Q4 2019.

  • New England Private Wealth Advisors reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • New England Private Wealth Advisors sold 1,375 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $249K.
  • New England Private Wealth Advisors first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • New England Private Wealth Advisors's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1.57M in Q4 2018.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.